About Apeiron Synthesis
Apeiron Synthesis is a Chemicals & Materials company based in Wrocław (Poland) founded in 2009 by Lukasz Gulajski and Michazl Bieniek. Catalyst services are manufactured and provided by Apeiron in Poland. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Apeiron Synthesis has raised $4.8 million across 3 funding rounds from investors including European Union, APER Ventures and Adamed. Its chief executive, as recorded, is Michazl Bieniek. Apeiron Synthesis offers products and services including Catalysts, Polymers, and Services. Its focus areas include Chemicals, Specialty Chemicals and Catalysts and Polymers. Its legal entity is Apeiron Synthesis S.A.
Company details
Apeiron Synthesis is engaged in developing and providing olefin metathesis technology for industrial chemical applications. Solutions are created to enhance chemical processes in various sectors. Robust catalysts, polymers, and end-to-end services are offered to partners. The technology is positioned as a cost-efficient and sustainable alternative to traditional catalytic transformations. Expertise is built over years to support innovation in the chemical industry.
- Headquarters Wrocław, Poland
- Founders Lukasz Gulajski, Michazl Bieniek
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website apeiron-synthesis.com
- Social LinkedIn X
- Legal Name Apeiron Synthesis S.A.
- Annual Revenue$954.85 K (USD)67as on Dec 31, 2022
- Net Profit-$190.21 K (USD)-431as on Dec 31, 2022
- EBITDA-$130.41 K (USD)-185as on Dec 31, 2022
- Total Equity Funding$4.8M (USD)
in 3 rounds
- Latest Funding Round$4.8M (USD), Series A
Dec 2022
- InvestorsEuropean Union
& 2 more
Products & Services of Apeiron Synthesis
Apeiron Synthesis offers a comprehensive portfolio of products and services, including Catalysts, Polymers, and Services.
Catalysts are provided for olefin metathesis applications.
Polymers are developed using metathesis technology solutions.
Services are offered for chemical process optimization.
Funding Insights of Apeiron Synthesis
Apeiron Synthesis has successfully raised a total of $4.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.8 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.8M
- Total Rounds 3
- Last Round Series A — $4.8M
- First Round $465,152
(Jan 2015)
- Investors Count 3
All 3 funding rounds of Apeiron Synthesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $4.8M | Series A | – | – | |
| Mar 2015 | $432,431 | Grant | – | – | |
| Jan 2015 | $465,152 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Apeiron Synthesis
Apeiron Synthesis has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, APER Ventures and Adamed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are focused on deeptech startups by APER Ventures. | aperventures.com | Warsaw, Poland | ||
Adamed is recognized as a Polish pharmaceutical-biotechnology company. | 1986 | adamed.com | Poland | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Apeiron Synthesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Apeiron Synthesis
5 people are tracked at Apeiron Synthesis (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Lukasz Gulajski | Co-Founder | Leadership |
Michazl Bieniek | Co-Founder & CEO | Leadership |
Michał Bieniek | Chief Executive Officer | Leadership |
Grazyna Szymanska Schellenberg | President | Leadership |
Joanna Drygajło - Gléver | Sales Manager And Technical Support | Team |
Complete people profiles for Apeiron Synthesis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Apeiron Synthesis
3 dated milestones of Apeiron Synthesis across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Apeiron Synthesis is founded.
- Funding First funding round of $465K.
- Funding Latest funding round, Series A, of $4.8M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apeiron Synthesis
Apeiron Synthesis was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Apeiron Synthesis is headquartered in Wrocław, Poland. It is registered at Wrocław, Lower Silesian Voivodeship, Poland.
Michazl Bieniek is the CEO of Apeiron Synthesis, as recorded in our data. They have also founded this company.
Apeiron Synthesis is a funded company, having raised a total of $4.8M across 3 funding rounds to date. The company's 1st funding round was a Grant of $465.15K, raised on Jan 2015.
Annual revenue of Apeiron Synthesis is $954.85K as on Dec 31, 2022.
Apeiron Synthesis is engaged in developing and providing olefin metathesis technology for industrial chemical applications. Solutions are created to enhance chemical processes in various sectors. Robust catalysts, polymers, and end-to-end services are offered to partners. The technology is positioned as a cost-efficient and sustainable alternative to traditional catalytic transformations. Expertise is built over years to support innovation in the chemical industry.
Apeiron Synthesis offers Catalysts, Polymers, and Services.
Apeiron Synthesis has 3 investors. Key investors include European Union, APER Ventures, and Adamed.
Apeiron Synthesis operates through Apeiron Synthesis S.A..